United States Biotechnology & Medical Research

Ardelyx, Inc. (ARDX)

Track

Track

Ardelyx Inc. experienced significant insider trading activity recently, with executives offloading over 1.2 million dollars in shares. This selling trend follows a disappointing earnings report where the company missed expectations by 40 percent. Consequently, the stock price has declined 44.7 percent over the last quarter, reflecting broader market pressure on the healthcare firm.
Ticker: ARDX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ardelyx, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Hohenleitner Susan Chief Financial Officer Officer
Transaction date
Sale
Price
90.18
Quantity 83,600 -40.8%
Value US$664,465
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
226.06
Quantity 70,499 -13.5%
Value US$3,418,092
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
338.49
Quantity 81,338 +44.8%
Value US$1,976,027
3.0
Brady James Parker Chief Human Resources Officer Officer
Transaction date
Sale
Price
3.86
Quantity 13,160 -5.1%
Value US$50,757
3.0
Brady James Parker Chief Human Resources Officer Officer
Transaction date
Sale
Price
3.86
Quantity 1,976 -0.8%
Value US$7,621
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
3.86
Quantity 2,575 -0.6%
Value US$9,932
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
3.86
Quantity 3,389 -0.8%
Value US$13,071
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
3.86
Quantity 2,598 -0.6%
Value US$10,020
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
3.86
Quantity 2,469 -0.8%
Value US$9,523
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
3.86
Quantity 17,281 -5.1%
Value US$66,651
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
3.86
Quantity 2,002 -0.6%
Value US$7,722
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
3.86
Quantity 2,652 -0.7%
Value US$10,228
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
3.86
Quantity 3,104 -0.9%
Value US$11,972
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
3.86
Quantity 1,734 -0.5%
Value US$6,688
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
3.86
Quantity 2,430 -0.7%
Value US$9,372
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
3.86
Quantity 3,089 -0.8%
Value US$11,914
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
3.86
Quantity 3,486 -0.9%
Value US$13,445
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
3.86
Quantity 19,178 -1.2%
Value US$73,968
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
3.86
Quantity 8,411 -0.5%
Value US$32,440
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
3.86
Quantity 15,976 -1.0%
Value US$61,618
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
3.86
Quantity 15,009 -0.9%
Value US$57,888
2.9
Hohenleitner Susan Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 2,650
Value US$10,680
2.8
Kelliher Mike Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 10,500
Value US$42,315
3.4
RAAB MICHAEL Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 44,500
Value US$179,335
3.8
Williams Laura A Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 10,500
Value US$42,315
2.5
Reilly Joseph James Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 4,700
Value US$18,941
3.0
Bishop John E Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 25,500
Value US$102,765
3.0
Brady James Parker Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 19,700
Value US$79,391
3.1
Foster Eric Duane Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 11,900
Value US$47,957
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
5.06
Quantity 41,668 -2.4%
Value US$210,923
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Planned sale
Price
5.99
Quantity 81,898 -17.8%
Value US$490,487
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Planned sale
Price
5.99
Quantity 81,898 -17.8%
Value US$490,487
3.8
LAURA WILLIAMS Officer Officer
Transaction date
Proposed sale
Price
5.84
Quantity 81,898
Value US$478,284
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
5.67
Quantity 41,666 -2.4%
Value US$236,346
3.4
RAAB MICHAEL Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.68
Quantity 41,666
Value US$236,663
3.4
MICHAEL RAAB Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.69
Quantity 125,000
Value US$711,250
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
6.27
Quantity 2,405 -0.6%
Value US$15,073
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
6.27
Quantity 2,427 -0.6%
Value US$15,211
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
6.27
Quantity 3,166 -0.7%
Value US$19,843
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
6.27
Quantity 14,028 -0.8%
Value US$87,920
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
6.27
Quantity 17,926 -1.0%
Value US$112,351
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
6.27
Quantity 7,861 -0.4%
Value US$49,269
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
6.27
Quantity 14,933 -0.8%
Value US$93,593
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
6.27
Quantity 2,478 -0.7%
Value US$15,531
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,870 -0.5%
Value US$11,720
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
6.27
Quantity 2,900 -0.8%
Value US$18,176
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,418 -0.3%
Value US$8,887
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,911 -0.4%
Value US$11,977
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
6.27
Quantity 2,157 -0.5%
Value US$13,519
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,503 -0.3%
Value US$9,420
2.9
Hohenleitner Susan Chief Financial Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,455 -0.6%
Value US$9,119
3.0
Brady James Parker Chief Human Resources Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,846 -0.7%
Value US$11,570
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Planned sale
Price
6.27
Quantity 1,036 -0.7%
Value US$6,493
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
6.27
Quantity 2,683 -1.8%
Value US$16,816
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
6.27
Quantity 2,306 -0.7%
Value US$14,453
2.8
Kelliher Mike Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 10,500
Value US$65,415
3.0
Brady James Parker Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 3,000
Value US$18,690
3.1
Foster Eric Duane Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 11,900
Value US$74,137
2.5
Reilly Joseph James Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 4,700
Value US$29,281
2.9
Hohenleitner Susan Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 2,650
Value US$16,510
3.8
Williams Laura A Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 10,500
Value US$65,415
3.4
RAAB MICHAEL Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 44,500
Value US$277,235
3.0
Bishop John E Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 3,700
Value US$23,051
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
6.28
Quantity 41,666 -2.3%
Value US$261,612
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
6.29
Quantity 41,668 -2.3%
Value US$261,954
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
5.84
Quantity 41,666 -2.2%
Value US$243,329
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
6.26
Quantity 41,666 -2.2%
Value US$260,621
3.4
MICHAEL RAAB Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.75
Quantity 166,666
Value US$958,330
4.0
MOTT DAVID M Non-Executive Director
Transaction date
Purchase
Price
5.84
Quantity 333,333 +11.2%
Value US$1,946,331
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
5.70
Quantity 2 -0.0%
Value US$11
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
5.71
Quantity 602 -0.4%
Value US$3,440
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
5.87
Quantity 4,387 -2.8%
Value US$25,730
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
5.70
Quantity 1 -0.0%
Value US$6
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
5.71
Quantity 386 -0.1%
Value US$2,206
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
5.87
Quantity 2,792 -0.8%
Value US$16,375
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-25 2026-08-21 S Sale
2.9
Hohenleitner Susan

Chief Financial Officer

Officer
83,600 -40.8%
90.18
US$664,465 		83,600 -40.8% 90.18 US$664,465
2026-08-25 2026-08-21 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
70,499 -13.5%
226.06
US$3,418,092 		70,499 -13.5% 226.06 US$3,418,092
2026-08-25 2026-08-21 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
81,338 +44.8%
338.49
US$1,976,027 		81,338 +44.8% 338.49 US$1,976,027
2026-08-25 2026-08-21 S Sale
3.0
Brady James Parker

Chief Human Resources Officer

Officer
13,160 -5.1%
3.86
US$50,757 		13,160 -5.1% 3.86 US$50,757
2026-08-25 2026-08-21 S Sale
3.0
Brady James Parker

Chief Human Resources Officer

Officer
1,976 -0.8%
3.86
US$7,621 		1,976 -0.8% 3.86 US$7,621
2026-08-25 2026-08-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
2,575 -0.6%
3.86
US$9,932 		2,575 -0.6% 3.86 US$9,932
2026-08-25 2026-08-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
3,389 -0.8%
3.86
US$13,071 		3,389 -0.8% 3.86 US$13,071
2026-08-25 2026-08-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
2,598 -0.6%
3.86
US$10,020 		2,598 -0.6% 3.86 US$10,020
2026-08-25 2026-08-21 S Sale
3.0
Bishop John E

See Remarks

Officer
2,469 -0.8%
3.86
US$9,523 		2,469 -0.8% 3.86 US$9,523
2026-08-25 2026-08-21 S Sale
3.0
Bishop John E

See Remarks

Officer
17,281 -5.1%
3.86
US$66,651 		17,281 -5.1% 3.86 US$66,651
2026-08-25 2026-08-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
2,002 -0.6%
3.86
US$7,722 		2,002 -0.6% 3.86 US$7,722
2026-08-25 2026-08-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
2,652 -0.7%
3.86
US$10,228 		2,652 -0.7% 3.86 US$10,228
2026-08-25 2026-08-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
3,104 -0.9%
3.86
US$11,972 		3,104 -0.9% 3.86 US$11,972
2026-08-25 2026-08-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,734 -0.5%
3.86
US$6,688 		1,734 -0.5% 3.86 US$6,688
2026-08-25 2026-08-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
2,430 -0.7%
3.86
US$9,372 		2,430 -0.7% 3.86 US$9,372
2026-08-25 2026-08-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
3,089 -0.8%
3.86
US$11,914 		3,089 -0.8% 3.86 US$11,914
2026-08-25 2026-08-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
3,486 -0.9%
3.86
US$13,445 		3,486 -0.9% 3.86 US$13,445
2026-08-25 2026-08-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
19,178 -1.2%
3.86
US$73,968 		19,178 -1.2% 3.86 US$73,968
2026-08-25 2026-08-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
8,411 -0.5%
3.86
US$32,440 		8,411 -0.5% 3.86 US$32,440
2026-08-25 2026-08-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
15,976 -1.0%
3.86
US$61,618 		15,976 -1.0% 3.86 US$61,618
2026-08-25 2026-08-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
15,009 -0.9%
3.86
US$57,888 		15,009 -0.9% 3.86 US$57,888
2026-08-21 2026-08-21 PrS Proposed sale
2.9
Hohenleitner Susan

Officer

Officer
2,650
4.03
US$10,680 		2,650 4.03 US$10,680
2026-08-21 2026-08-21 PrS Proposed sale
2.8
Kelliher Mike

Officer

Officer
10,500
4.03
US$42,315 		10,500 4.03 US$42,315
2026-08-21 2026-08-21 PrS Proposed sale
3.4
RAAB MICHAEL

Officer

Officer
44,500
4.03
US$179,335 		44,500 4.03 US$179,335
2026-08-21 2026-08-21 PrS Proposed sale
3.8
Williams Laura A

Officer

Officer
10,500
4.03
US$42,315 		10,500 4.03 US$42,315
2026-08-21 2026-08-21 PrS Proposed sale
2.5
Reilly Joseph James

Officer

Officer
4,700
4.03
US$18,941 		4,700 4.03 US$18,941
2026-08-21 2026-08-21 PrS Proposed sale
3.0
Bishop John E

Officer

Officer
25,500
4.03
US$102,765 		25,500 4.03 US$102,765
2026-08-21 2026-08-21 PrS Proposed sale
3.0
Brady James Parker

Officer

Officer
19,700
4.03
US$79,391 		19,700 4.03 US$79,391
2026-08-21 2026-08-21 PrS Proposed sale
3.1
Foster Eric Duane

Officer

Officer
11,900
4.03
US$47,957 		11,900 4.03 US$47,957
2026-07-17 2026-07-15 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,668 -2.4%
5.06
US$210,923 		41,668 -2.4% 5.06 US$210,923
2026-06-22 2026-06-18 PlS Planned sale
3.8
Williams Laura A

Chief Patient Officer

Officer
81,898 -17.8%
5.99
US$490,487 		81,898 -17.8% 5.99 US$490,487
2026-06-22 2026-06-18 PlS Planned sale
3.8
Williams Laura A

Chief Patient Officer

Officer
81,898 -17.8%
5.99
US$490,487 		81,898 -17.8% 5.99 US$490,487
2026-06-18 2026-06-18 PrS Proposed sale
3.8
LAURA WILLIAMS

Officer

Officer
81,898
5.84
US$478,284 		81,898 5.84 US$478,284
2026-06-17 2026-06-15 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.4%
5.67
US$236,346 		41,666 -2.4% 5.67 US$236,346
2026-06-17 2026-06-15 PrS Proposed sale
3.4
RAAB MICHAEL

Officer; Director

Executive Director
41,666
5.68
US$236,663 		41,666 5.68 US$236,663
2026-06-15 2026-06-15 PrS Proposed sale
3.4
MICHAEL RAAB

Director; Officer

Executive Director
125,000
5.69
US$711,250 		125,000 5.69 US$711,250
2026-05-22 2026-05-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
2,405 -0.6%
6.27
US$15,073 		2,405 -0.6% 6.27 US$15,073
2026-05-22 2026-05-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
2,427 -0.6%
6.27
US$15,211 		2,427 -0.6% 6.27 US$15,211
2026-05-22 2026-05-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
3,166 -0.7%
6.27
US$19,843 		3,166 -0.7% 6.27 US$19,843
2026-05-22 2026-05-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
14,028 -0.8%
6.27
US$87,920 		14,028 -0.8% 6.27 US$87,920
2026-05-22 2026-05-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
17,926 -1.0%
6.27
US$112,351 		17,926 -1.0% 6.27 US$112,351
2026-05-22 2026-05-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
7,861 -0.4%
6.27
US$49,269 		7,861 -0.4% 6.27 US$49,269
2026-05-22 2026-05-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
14,933 -0.8%
6.27
US$93,593 		14,933 -0.8% 6.27 US$93,593
2026-05-22 2026-05-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
2,478 -0.7%
6.27
US$15,531 		2,478 -0.7% 6.27 US$15,531
2026-05-22 2026-05-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
1,870 -0.5%
6.27
US$11,720 		1,870 -0.5% 6.27 US$11,720
2026-05-22 2026-05-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
2,900 -0.8%
6.27
US$18,176 		2,900 -0.8% 6.27 US$18,176
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,418 -0.3%
6.27
US$8,887 		1,418 -0.3% 6.27 US$8,887
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,911 -0.4%
6.27
US$11,977 		1,911 -0.4% 6.27 US$11,977
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
2,157 -0.5%
6.27
US$13,519 		2,157 -0.5% 6.27 US$13,519
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,503 -0.3%
6.27
US$9,420 		1,503 -0.3% 6.27 US$9,420
2026-05-22 2026-05-21 S Sale
2.9
Hohenleitner Susan

Chief Financial Officer

Officer
1,455 -0.6%
6.27
US$9,119 		1,455 -0.6% 6.27 US$9,119
2026-05-22 2026-05-21 S Sale
3.0
Brady James Parker

Chief Human Resources Officer

Officer
1,846 -0.7%
6.27
US$11,570 		1,846 -0.7% 6.27 US$11,570
2026-05-22 2026-05-21 PlS Planned sale
2.5
Reilly Joseph James

See Remarks

Officer
1,036 -0.7%
6.27
US$6,493 		1,036 -0.7% 6.27 US$6,493
2026-05-22 2026-05-21 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
2,683 -1.8%
6.27
US$16,816 		2,683 -1.8% 6.27 US$16,816
2026-05-22 2026-05-21 S Sale
3.0
Bishop John E

See Remarks

Officer
2,306 -0.7%
6.27
US$14,453 		2,306 -0.7% 6.27 US$14,453
2026-05-19 2026-05-19 PrS Proposed sale
2.8
Kelliher Mike

Officer

Officer
10,500
6.23
US$65,415 		10,500 6.23 US$65,415
2026-05-19 2026-05-19 PrS Proposed sale
3.0
Brady James Parker

Officer

Officer
3,000
6.23
US$18,690 		3,000 6.23 US$18,690
2026-05-19 2026-05-19 PrS Proposed sale
3.1
Foster Eric Duane

Officer

Officer
11,900
6.23
US$74,137 		11,900 6.23 US$74,137
2026-05-19 2026-05-19 PrS Proposed sale
2.5
Reilly Joseph James

Officer

Officer
4,700
6.23
US$29,281 		4,700 6.23 US$29,281
2026-05-19 2026-05-19 PrS Proposed sale
2.9
Hohenleitner Susan

Officer

Officer
2,650
6.23
US$16,510 		2,650 6.23 US$16,510
2026-05-19 2026-05-19 PrS Proposed sale
3.8
Williams Laura A

Officer

Officer
10,500
6.23
US$65,415 		10,500 6.23 US$65,415
2026-05-19 2026-05-19 PrS Proposed sale
3.4
RAAB MICHAEL

Officer

Officer
44,500
6.23
US$277,235 		44,500 6.23 US$277,235
2026-05-19 2026-05-19 PrS Proposed sale
3.0
Bishop John E

Officer

Officer
3,700
6.23
US$23,051 		3,700 6.23 US$23,051
2026-05-19 2026-05-15 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.3%
6.28
US$261,612 		41,666 -2.3% 6.28 US$261,612
2026-04-17 2026-04-15 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,668 -2.3%
6.29
US$261,954 		41,668 -2.3% 6.29 US$261,954
2026-03-18 2026-03-16 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.2%
5.84
US$243,329 		41,666 -2.2% 5.84 US$243,329
2026-02-25 2026-02-24 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.2%
6.26
US$260,621 		41,666 -2.2% 6.26 US$260,621
2026-02-24 2026-02-24 PrS Proposed sale
3.4
MICHAEL RAAB

Director; Officer

Executive Director
166,666
5.75
US$958,330 		166,666 5.75 US$958,330
2026-02-23 2026-02-20 B Purchase
4.0
MOTT DAVID M
Non-Executive Director
333,333 +11.2%
5.84
US$1,946,331 		333,333 +11.2% 5.84 US$1,946,331
2026-02-23 2026-02-20 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
2 -0.0%
5.70
US$11 		2 -0.0% 5.70 US$11
2026-02-23 2026-02-20 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
602 -0.4%
5.71
US$3,440 		602 -0.4% 5.71 US$3,440
2026-02-23 2026-02-20 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
4,387 -2.8%
5.87
US$25,730 		4,387 -2.8% 5.87 US$25,730
2026-02-23 2026-02-20 S Sale
3.0
Bishop John E

See Remarks

Officer
1 -0.0%
5.70
US$6 		1 -0.0% 5.70 US$6
2026-02-23 2026-02-20 S Sale
3.0
Bishop John E

See Remarks

Officer
386 -0.1%
5.71
US$2,206 		386 -0.1% 5.71 US$2,206
2026-02-23 2026-02-20 S Sale
3.0
Bishop John E

See Remarks

Officer
2,792 -0.8%
5.87
US$16,375 		2,792 -0.8% 5.87 US$16,375
Explore more

More insider trading research around Ardelyx, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America